No results for ‘’
Natco Pharma Ltd
NSE: NATCOPHARM BSE: 524816
₹815.35
(0.40%)
Thu, 17 Sept 2026, 00:03 pm
Market Cap (in Cr)14669.1
PE Ratio12.76
Dividend0.55
Health Technology
Pharmaceuticals: Major
24.5KNatco Pharma Deals
| Client Name | Deal Type | Order Side | QTY | Avg Price | Date |
|---|---|---|---|---|---|
| GRAVITON RESEARCH CAPITAL LLP | bulk | Buy | 1199044 | 904.19 | 26 Nov 2025 |
| GRAVITON RESEARCH CAPITAL LLP | bulk | Sell | 1199411 | 904.93 | 26 Nov 2025 |
| GRAVITON RESEARCH CAPITAL LLP | bulk | Buy | 1784917 | 929.71 | 24 Apr 2025 |
| GRAVITON RESEARCH CAPITAL LLP | bulk | Sell | 1784917 | 930.19 | 24 Apr 2025 |
| GRAVITON RESEARCH CAPITAL LLP | bulk | Sell | 971727 | 891.03 | 14 Feb 2025 |
| GRAVITON RESEARCH CAPITAL LLP | bulk | Buy | 971727 | 890.86 | 14 Feb 2025 |
| THE JUPITER GLOBAL FUND-JUPITER INDIA SELECT | block | Buy | 198742 | 1039.15 | 21 Feb 2024 |
| JUPITER SOUTH ASIA INVESTMENT COMPANY LIMITED | block | Sell | 198742 | 1039.15 | 21 Feb 2024 |
| MARSHALLWACEINVESTMENTSTRATEGIESMARKETNEUTRALTOPSFUND | block | Buy | 149926 | 859.2 | 25 Jan 2024 |
| BNP PARIBAS ARBITRAGE | block | Sell | 149926 | 859.2 | 25 Jan 2024 |
Showing 1–10 of 90
Rows per page: